WASHINGTON, D.C. - The U.S. Food and Drug Administration issued a recall notice stating that Alembic Pharmaceuticals Limited has begun a nationwide recall of its Telmisartan Tablets, USP, 20 mg because of a labeling error. Telmisartan is used to treat hypertension and helps to lower a patient's blood pressure. The Telmisartan tablet … [Read more...] about Telmisartan Tablet Elevated Potassium Wrongful Death Lawsuits